CMS Adopts Final Rule Phasing Out Fax and Mail for Health Care Claims Attachments
The Centers for Medicare & Medicaid Services (CMS) issued a final rule on national standards for electronic claims attachments and signatures,...
The Centers for Medicare & Medicaid Services (CMS) is expanding Medicare coverage for genetic testing through the MolDX program administered by Palmetto GBA.
CMS announced two new local coverage determinations (LCDs) to cover diagnostic tests used to evaluate and manage care for patients suspected of having hereditary transthyretin amyloidosis:
- Genetic Testing for Heritable Thoracic Aortic Disease (L39933)
- Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis (L39935)
The LCDs will take effect Aug. 17 in 23 states.
Source:
https://www.cap.org/advocacy/latest-news-and-practice-data/july-8-2025
CMS Clarifies CLIA Certification Requirements for Remote Cytology
The Centers for Medicare & Medicaid Services (CMS) recently clarified Clinical Laboratory Improvement Act (CLIA) certification requirements for...
TELCOR Promotions - April 2026
Lincoln, NE – April 2026 TELCOR is proud to announce the promotion ofJoni Fitzgerald to Senior Revenue Cycle Supervisor, Natalie Helkenn to RCS...